Differential blood pressure reductions by angiotensin receptor blocker plus calcium channel blocker or diuretic in elderly hypertension with or without obesity

Journal of the American Society of Hypertension

Volumn 6, Issue 6, 2012, Pages 393-398

  Kato, Johji ^a   Yokota, Naoto ^a   Tamaki, Noboru ^a   Kariya, Sumito ^a   Kita, Toshihiro ^b   Ayabe, Takao ^a   Eto, Tanenao ^c   Kitamura, Kazuo ^b  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c Miyazaki Prefectural Health Foundation   (Japan)

Author keywords

Combination therapy; hypertension in the elderly; obesity

Indexed keywords

ALDOSTERONE; AMLODIPINE; AZELNIDIPINE; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INDAPAMIDE; OLMESARTAN; POTASSIUM; TRICHLORMETHIAZIDE; URIC ACID;

AGED; ALDOSTERONE BLOOD LEVEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRESCRIPTION; PRIORITY JOURNAL; PULSE RATE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BODY MASS INDEX; CALCIUM CHANNEL BLOCKERS; COHORT STUDIES; DIURETICS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; IMIDAZOLES; MALE; OBESITY; TETRAZOLES; TREATMENT OUTCOME;

EID: 84870457767     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2012.09.001     Document Type: Article

References (22)

1. SHEP Cooperative Research Group Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP) JAMA 265 1991 3255 3264
2. J.A. Staessen, R. Fagard, L. Thijs, H. Celis, G.G. Arabidze, and W.H. Birkenhäger Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators Lancet 350 1997 757 764
3. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2002 2981 2997
4. N.S. Beckett, R. Peters, A.E. Fletcher, J.A. Staessen, L. Liu, and D. Dumitrascu Treatment of hypertension in patients 80 years of age or older N Engl J Med 358 2008 1887 1898
5. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, and J.L. Izzo Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 42 2003 1206 1252
6. W.S. Aronow, J.L. Fleg, C.J. Pepine, N.T. Artinian, G. Bakris, and A.S. Brown ACCF/AHA 2011 expert consensus document on hypertension in the elderly J Am Soc Hypertens 5 2011 259 352
7. G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, and G. Germano 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens 25 2007 1105 1187
8. G. Mancia, S. Laurent, E. Agabiti-Rosei, E. Ambrosioni, M. Burnier, and M.J. Caulfield Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document J Hypertens 27 2009 2121 2158
9. Japanese Society of Hypertension Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004) Hypertens Res 29 2006 S1 S105
10. T. Ogihara, K. Kikuchi, H. Matsuoka, T. Fujita, J. Higaki, and M. Horiuchi The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009) Hypertens Res 32 2009 3 107
11. G.L. Bakris, M. Williams, L. Dworkin, W.J. Elliott, M. Epstein, and R. Toto Preserving renal function in adults with hypertension and diabetes: a consensus approach Am J Kidney Dis 36 2000 646 661
12. J. Kato, N. Yokota, N. Tamaki, S. Kariya, T. Kita, and T. Ayabe Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension Hypertens Res 34 2011 331 335
13. Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity New criteria for 'obesity disease' in Japan Circ J 66 2002 987 992
14. M. Kanazawa, N. Yoshiike, T. Osaka, Y. Numba, P. Zimmet, and S. Inoue Criteria and classification of obesity in Japan and Asia-Oceania World Rev Nutr Diet 94 2005 1 12
15. J. Kato, K. Kobayashi, T. Etoh, M. Tanaka, K. Kitamura, and T. Imamura Plasma adrenomedullin concentration in patients with heart failure J Clin Endocrinol Metab 81 1996 180 183
16. N.M. Kaplan, and R.G. Victor Kaplan's Clinical Hypertension 10th ed. 2010 Lippincott Williams & Wilkins Philadelphia
17. M. Nagase, and T. Fujita Mineralocorticoid receptor activation in obesity hypertension Hypertens Res 32 2009 649 657
18. R.S. McKelvie, S. Yusuf, D. Pericak, A. Avezum, R.J. Burns, and J. Probstfield Comparison of candesartan, enalapril, and their combination in congestive heart failure: Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators Circulation 100 1999 1056 1064
19. M. Ehrhart-Bornstein, V. Lamounier-Zepter, A. Schraven, J. Langenbach, H.S. Willenberg, and A. Barthel Human adipocytes secrete mineralocorticoid- releasing factors Proc Natl Acad Sci USA 100 2003 14211-13216
20. G.L. Bakris, R.D. Toto, P.A. McCullough, R. Rocha, D. Purkayastha, and P. Davis Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study Kidney Int 73 2008 1303 1309
21. K. Jamerson, M.A. Weber, G.L. Bakris, B. Dahlöf, B. Pitt, and V. Shi Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients N Engl J Med 359 2008 2417 2428
22. G.L. Bakris, P.A. Sarafidis, M.R. Weir, B. Dahlöf, B. Pitt, and K. Jamerson Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial Lancet 375 2010 1173 1181